...
首页> 外文期刊>Endocrine. >Comparison of the effect of 'metabolically healthy but obese' and 'metabolically abnormal but not obese' phenotypes on development of diabetes and cardiovascular disease in Chinese
【24h】

Comparison of the effect of 'metabolically healthy but obese' and 'metabolically abnormal but not obese' phenotypes on development of diabetes and cardiovascular disease in Chinese

机译:'代谢健康但肥胖'和“代谢异常但不肥胖”表型对糖尿病和心血管疾病发展的影响的比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The present study was designed to determine the prevalence of 'metabolically healthy but obese' (MHO) and 'metabolically abnormal but not obese' (MANO) phenotypes in Chinese population, and to investigate the association of these two phenotypes with the risk of diabetes and cardiovascular disease (CVD). A total of 2,764 subjects aged 30-90 were followed up over a mean period of 43.80 +/- 11.25 months. The metabolic syndrome was defined according to the joint committee for developing Chinese guidelines on prevention and treatment of dyslipidemia in adults. Subjects with body fat percentage (BF %) >25 % for men or BF % >35 % for women were defined as being obese. The proportion of MHO and MANO phenotypes were 22.9, 7.6 % in men, and 26.2, 6.0 % in women, respectively. The MANO phenotype was associated with increased risk for diabetes both in men [hazard ratios (HR): 4.44 (1.21-16.26)] and women [HR: 8.68 (2.87-24.96)] after adjustment of age, serum total cholesterol (TC), triglycerides (TG), and family history of diabetes. This association held for CVD in women [HR: 2.87 (1.44-5.73)], but not in men after adjustment of age, serum TC, TG, and family history of CVD. No association was observed between the MHO phenotype and incident diabetes or CVD. MHO and MANO phenotypes are common in Chinese population. Metabolic risk factors appeared to play a more important role in the development of diabetes and CVD than body fat alone.
机译:本研究旨在确定“代谢健康,但肥胖”(MHO)和“代谢异常但不肥胖”(MANO)表型的患病率,并探讨这两种表型与糖尿病风险的关联心血管疾病(CVD)。总共2,764名受试者30-90岁,平均时间为43.80 +/- 11.25个月。代谢综合征根据联合委员会,制定中国预防和治疗血脂血症的预防和治疗成人的联合委员会。男性体脂百分比(BF%)> 25%的受试者为女性的35%被定义为肥胖。 MHO和MANO表型的比例分别为22.9%,7.6%,女性分别为26.2%,6.0%。 Mano表型在调整年龄调整后,MANO表型患有糖尿病患者的风险增加[危险比(HR):4.44(1.21-16.26)]和妇女[HR:8.68(2.87-24.96)],血清总胆固醇(TC) ,甘油三酯(TG)和糖尿病的家族史。该协会在妇女中持有CVD [HR:2.87(1.44-5.73)],但在调整年龄,血清TC,TG和CVD家族历史后,男性没有。 MHO表型和入射糖尿病或CVD之间没有观察到关联。 MHO和MANO表型在中国人口中很常见。代谢风险因素似乎在糖尿病和CVD的开发中起比单独的体脂发挥更重要的作用。

著录项

  • 来源
    《Endocrine.》 |2015年第1期|共9页
  • 作者单位

    Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Shanghai Diabet Inst Shanghai 200233 Peoples;

    Shanghai Key Lab Diabet Mellitus Shanghai 200233 Peoples R China;

    Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Shanghai Diabet Inst Shanghai 200233 Peoples;

    Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Shanghai Diabet Inst Shanghai 200233 Peoples;

    Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Shanghai Diabet Inst Shanghai 200233 Peoples;

    Tongji Univ Sch Med Shanghai Peoples Hosp 10 Shanghai 200092 Peoples R China;

    Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Shanghai Diabet Inst Shanghai 200233 Peoples;

    Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Shanghai Diabet Inst Shanghai 200233 Peoples;

    Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6 Shanghai Diabet Inst Shanghai 200233 Peoples;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内分泌腺疾病及代谢病;
  • 关键词

    Obesity; Metabolic syndrome; Diabetes; CVD;

    机译:肥胖症;代谢综合征;糖尿病;CVD;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号